{{Rsnum
|rsid=12327666
|Gene=RLN3
|Chromosome=19
|position=14029109
|Orientation=plus
|GMAF=0.06657
|Gene_s=RLN3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 8.0 | 92.0
| HCB | 1.5 | 14.6 | 83.9
| JPT | 0.0 | 12.4 | 87.6
| YRI | 2.0 | 22.4 | 75.5
| ASW | 0.0 | 19.3 | 80.7
| CHB | 1.5 | 14.6 | 83.9
| CHD | 0.0 | 5.5 | 94.5
| GIH | 2.0 | 12.9 | 85.1
| LWK | 1.8 | 16.4 | 81.8
| MEX | 0.0 | 5.2 | 94.8
| MKK | 1.3 | 14.7 | 84.0
| TSI | 1.0 | 5.9 | 93.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23251661
  |Trait=Obesity-related traits
  |Title=Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.
  |RiskAllele=A
  |Pval=9E-6
  |OR=.03
  |ORtxt=[NR]  %energy increase
  |OA=1
}}

{{PMID Auto
|PMID=21693553
|Title=Relaxin polymorphisms associated with metabolic disturbance in patients treated with antipsychotics.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}